Novartis AG ADR (NYSE:NVS) shares, rose in value, with the stock price up by 2.30% to the previous day’s close as strong demand from buyers drove the stock to $115.17.
Actively observing the price movement in the recent trading, the stock is buoying the session at $112.58. The PE ratio was 18.03 over 12-month period. Referring to stock’s 52-week performance, its high was $120.92, and the low was $96.06. On the whole, NVS has fluctuated by 1.48% over the past month.
With the market capitalization of Novartis AG ADR currently standing at about $218.54 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June. The company’s Forward Dividend Ratio is 3.87, with its dividend yield at 3.36%.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that NVS’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 2.61, with the price of NVS currently trading nearly 3.70% and 4.36% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 61.71, while the 7-day volatility ratio is showing 0.82% which for the 30-day chart, stands at 1.55%. Furthermore, Novartis AG ADR (NVS)’s beta value is 0.58, and its average true range (ATR) is 2.01.
A comparison of Novartis AG ADR (NVS) with its peers suggests the former has fared considerably weaker in the market. NVS showed an intraday change of 2.30% in today’s session so far, and over the past year, it grew by 15.54%%.
Data on historical trading for Novartis AG ADR (NYSE:NVS) indicates that the trading volumes over the past 3 months, they’ve averaged 2.26 million. According to company’s latest data on outstanding shares, there are 1.96 billion shares outstanding.
Nearly 0.00% of Novartis AG ADR’s shares belong to company insiders and institutional investors own 7.34% of the company’s shares. The stock has risen by 18.35% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the NVS stock heading into the next quarter.
